Related Experiment Video
Updated: Dec 28, 2025

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
Metabolic Dysfunction in Hutchinson-Gilford Progeria Syndrome
Ray Kreienkamp1,2, Susana Gonzalo1
1Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St Louis, MO 63104, USA.
Insights
Hutchinson-Gilford Progeria Syndrome (HGPS) involves premature aging and cardiovascular issues. Metabolic interventions show promise for extending lifespan in HGPS animal models, offering new therapeutic avenues.
Area of Science:
- Gerontology
- Molecular Biology
- Genetics
Background:
- Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare genetic disorder characterized by rapid, premature aging.
- Patients with HGPS exhibit cardiovascular dysfunction, bone abnormalities, and adipose changes, mirroring aspects of normal aging.
- Current HGPS research targets aging pathways like inflammation and DNA damage, but metabolic dysfunction is also a significant, less-understood factor.
Purpose of the Study:
- To investigate the role of metabolism in Hutchinson-Gilford Progeria Syndrome.
- To explore the therapeutic potential of metabolic interventions for HGPS.
- To enhance understanding of HGPS pathophysiology and identify novel treatment strategies.
Main Methods:
- Review of existing literature on HGPS and aging.
- Analysis of metabolic pathways implicated in HGPS.
- Examination of recent findings from HGPS animal models regarding metabolic interventions.
Main Results:
- HGPS patients display severe metabolic problems.
- Metabolic interventions in HGPS animal models have led to significant lifespan improvements.
- These findings highlight the critical role of metabolism in HGPS progression.
Conclusions:
- Metabolism is a key contributor to the pathophysiology of Hutchinson-Gilford Progeria Syndrome.
- Targeting metabolic pathways represents a promising therapeutic strategy for HGPS.
- Further research into HGPS metabolism could yield crucial advancements for treating this disease.
Abstract:
Hutchinson-Gilford Progeria Syndrome (HGPS) is a segmental premature aging disease causing patient death by early teenage years from cardiovascular dysfunction. Although HGPS does not totally recapitulate normal aging, it does harbor many similarities to the normal aging process, with patients also developing cardiovascular disease, alopecia, bone and joint abnormalities, and adipose changes. It is unsurprising, then, that as physicians and scientists have searched for treatments for HGPS, they have targeted many pathways known to be involved in normal aging, including inflammation, DNA damage, epigenetic changes, and stem cell exhaustion. Although less studied at a mechanistic level, severe metabolic problems are observed in HGPS patients. Interestingly, new research in animal models of HGPS has demonstrated impressive lifespan improvements secondary to metabolic interventions. As such, further understanding metabolism, its contribution to HGPS, and its therapeutic potential has far-reaching ramifications for this disease still lacking a robust treatment strategy.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Lysosomal Hydrolases

